About a third of melanomas begin with benign moles. Now, researchers at Massachusetts General Hospital have found an immune mechanism…
2021
Diagnosis of melanoma by imaging mass spectrometry: Development and validation of a melanoma prediction model
This study sought to report the development and validation of a melanoma prediction model from spatially resolved multivariate protein expression profiles generated by Imaging Mass Spectrometry (IMS).
mRNA-based therapeutic cancer vaccine enters Phase II trial
BioNTech is evaluating its investigational therapeutic mRNA-based cancer vaccine, BNT111, in combination with Libtayo® (cemiplimab) for the treatment of melanoma.
Common moles could serve as players in battling melanoma and preventing its recurrence
Researchers at Massachusetts General Hospital (MGH) have found that a subset of white blood cells known as CD4+ T cells reside naturally in moles on the body and could be activated as part of a novel strategy to treat melanoma and generate a potent immunity against its recurrence.